This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (581) Public (e)Health, Digital Epidemiology and Public Health Informatics (843) Text-messaging (SMS, WeChat etc)-Based Interventions (686) Vaccination and Immunization in the Digital Age (395) Prevention and Health Promotion (1108) Cost-Effectiveness and Economics (285)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/63938, first published .
Effectiveness of Text Messaging Nudging to Increase Coverage of Influenza Vaccination Among Older Adults in Norway (InfluSMS Study): Protocol for a Randomized Controlled Trial

Effectiveness of Text Messaging Nudging to Increase Coverage of Influenza Vaccination Among Older Adults in Norway (InfluSMS Study): Protocol for a Randomized Controlled Trial

Effectiveness of Text Messaging Nudging to Increase Coverage of Influenza Vaccination Among Older Adults in Norway (InfluSMS Study): Protocol for a Randomized Controlled Trial

Authors of this article:

Bo T Hansen1 Author Orcid Image ;   Ole Klungsøyr2 Author Orcid Image ;   Angela S Labberton3 Author Orcid Image ;   Lauri Sääksvuori4, 5 Author Orcid Image ;   Kjersti M Rydland1 Author Orcid Image ;   Liz E Ødeskaug6 Author Orcid Image ;   Torbjørn Wisløff7, 8 Author Orcid Image ;   Hinta Meijerink1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Bo T Hansen   1 , PhD ;   Ole Klungsøyr   2 , PhD ;   Angela S Labberton   3 , PhD ;   Lauri Sääksvuori   4, 5 , PhD ;   Kjersti M Rydland   1 , Cand Pharm ;   Liz E Ødeskaug   6 , MSc ;   Torbjørn Wisløff   7, 8 , PhD ;   Hinta Meijerink   1 , PhD

1 Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway

2 Department of Research and Innovation, Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway

3 Division of Health Services, Norwegian Institute of Public Health, Oslo, Norway

4 Centre for Health and Social Economics, Finnish Institute for Health and Welfare, Helsinki, Finland

5 INVEST Research Flagship Center, University of Turku, Turku, Finland

6 Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway

7 Health Services and Research Unit, Akershus University Hospital, Oslo, Norway

8 Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Corresponding Author:

  • Bo T Hansen, PhD
  • Department of Infection Control and Vaccines
  • Norwegian Institute of Public Health
  • Postboks 222 Skøyen
  • Oslo, 0213
  • Norway
  • Phone: 47 21077000
  • Email: boterning.hansen@fhi.no